Will produce a new, scalable route to Cannabidiol.

OxStem Immuno aims to develop small molecule drugs that augment macrophage efferocytosis in
vitro and enhance tissue repair in vivo. These therapies will supercede the need for cell transplantation
or cytokine therapy in the context of tissue repair for chronic wounds and a range of inflammatory
conditions.

OxStem Beta will generate novel therapies to stimulate formation of new beta cells in the pancreas
(neogenesis) by targeting pathways that are normally only active during development or following
pancreatic injury.

A not for profit company providing a solution and accreditation to businesses that work to bring their workforce out of multidimensional poverty

Developing a brain implant to treat a variety of diseases.

LED spin-out using Perovskite technology.

Development and application of bacterial biosensors for detection and quantification of environmental contamination, including organics and metals, on-site and in real-time.

Company developing AI-based learning support applications.

A company being established to commercialise Zooniverse technology

Software development for a novel biomarker to detect coronary heart disease.

Cybersecurity in a post quantum world

Sensor technology based on optical microcavities used in scientific instruments and chemical sensors.

Demonstration of iSCAT as a single molecule mass spectrometer.

Custom made helmet using 3D printing.

Therapeutics biotech company developing proprietary drug delivery platform technology.

Developing state-of-the-art machine learning technology for autonomous vehicles and traffic modeling applications.

Development of geothermal technologies

Catalyst production and processes for upgrading pyrolysis oil to high octane gasoline.

Low cost three dimensional imaging of museum artifacts.

DeepReason.ai offers a Knowledge Graph Management System that can integrate seamlessly with various enterprise, and public, data sources to perform fast and intelligent reasoning